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In Brazil and other regions of the world, Pseudomonas aeruginosa and Acinetobacter spp. have emerged as 
important agents of nosocomial infection and are commonly involved in outbreaks. The main objective of the 
present study was to evaluate the genetic relationship among P. aeruginosa and Acinetobacter spp. isolated 
from patients in a public university hospital in northwestern Paraná, Brazil, and report their antimicrobial 
resistance profile. A total of 75 P. aeruginosa and 94 Acinetobacter spp. isolates were phenotypically 
identified and tested for antibiotic susceptibility using automated methodology. Polymyxin B was tested by 
disk diffusion for P. aeruginosa. Metallo-b-lactamase (MBL) was detected using a disk approximation test. 
Genotyping was performed using enterobacterial repetitive intergenic consensus polymerase chain reaction 
(ERIC-PCR). Approximately 55% of the P. aeruginosa isolates and 92% of the Acinetobacter spp. isolates 
were multiresistant, but none were MBL-producers. ERIC-PCR revealed the presence of small clusters of 
carbapenem-resistant Acinetobacter spp., most likely OXA-type carbapenemase producers. Furthermore, 
high genetic diversity in P. aeruginosa and Acinetobacter spp. clinical isolates was observed, suggesting 
that cross-transmission is not very frequent in the studied hospital.
Uniterms: Pseudomonas aeruginosa/antimicrobial resistance profile. Pseudomonas aeruginosa/genetic 
study. Acinetobacter spp./antimicrobial resistance profile. Acinetobacter spp./genetic study. Antimicrobial 
resistance. Bacterial typing.
No Brasil, bem como em outras regiões do mundo, Pseudomonas aeruginosa e Acinetobacter spp. 
surgiram como importantes agentes de infecção nosocomial e são comumente envolvidos em surtos. 
O objetivo principal deste estudo foi descrever a relação genética de P. aeruginosa e Acinetobacter 
spp. isoladas de pacientes internados em hospital universitário público do noroeste do Paraná - Brasil 
e reportar o perfil de resistência dessas bactérias. Um total de 75 P. aeruginosa e 94 Acinetobacter spp. 
isolados foi fenotipicamente identificado e testado para a suscetibilidade aos antibióticos por metodologia 
automatizada. A polimixina B foi testada por difusão em disco para P. aeruginosa. Metalo-b-lactamase 
(MBL) foi detectada por disco-aproximação. Análise genotípica foi realizada por enterobacterial repetitive 
intergenic consensus polymerase chain reaction (ERIC-PCR). Aproximadamente 55% dos isolados de P. 
aeruginosa e 92% de Acinetobacter spp. isolados foram multirresistentes, mas nenhum foi produtor de 
MBL. Os resultados de ERIC-PCR revelaram pequenos grupamentos de Acinetobacter spp. resistentes 
aos carbapenêmicos, provavelmente pela produção de carbapenemases do tipo OXA. Além disso, alta 
diversidade genética entre os isolados de P. aeruginosa e Acinetobacter spp. foi observada, sugerindo 
que a transmissão cruzada destas espécies bacterianas não é muito frequente em nosso hospital.
Unitermos: Pseudomonas aeruginosa/perfil de resistência. Pseudomonas aeruginosa/estudo genético. 
Acinetobacter spp./perfil de resistência. Acinetobacter spp./estudo genético. Resistência antimicrobiana. 
Tipagem bacteriana.
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INTRODUCTION
Pseudomonas aeruginosa and Acinetobacter spp. 
have been the cause of nosocomial outbreaks worldwide 
(Cortes et al., 2009; Hosoglu et al., 2011), including in 
Brazil (Brito et al., 2003; Prates et al., 2011), where mul-
tidrug resistance is common among these isolates (Rossi, 
2011). Carbapenems often represent the only effective 
treatment. However, carbapenem-resistant isolates have 
frequently been detected, leading clinicians to resume 
the use of older classes of antibiotics, such as polymyxins 
(Giamarellou, 2010). The production of carbapenemase 
enzymes has been an important mechanism of resistance 
in these bacteria. Metallo-β-lactamases (MBLs), enzymes 
able to hydrolyze all β-lactam antibiotics with the ex-
ception of monobactams, are particularly common in P. 
aeruginosa, and the genes that encode them are carried 
by highly mobile elements that play an important role in 
hospital environments (Cornaglia, Giamarellou, Rossolini, 
2011).
Enterobacterial repetitive intergenic consensus-
polymerase chain reaction (ERIC-PCR) has shown good 
applicability in typing A. baumannii and P. aeruginosa 
(Presterl et al., 1997; Syrmis et al., 2004; Kidd et al., 
2011). Although some studies have used ERIC-PCR to 
epidemiologically study P. aeruginosa and Acinetobacter 
spp. nosocomial isolates in Brazil (Costa et al., 2006; 
Saalfeld et al., 2009; Stehling, Leite, Silveira, 2010; 
Ferreira et al., 2011; Viana et al., 2011), the specific 
epidemiology of these microorganisms remains unknown.
The main objective of the present study was to de-
scribe the genetic relationship among P. aeruginosa and 
Acinetobacter spp. clinical isolates using ERIC-PCR and 
report their resistance profiles against antimicrobial agents 
that are routinely used in a public university hospital in 
northwestern Paraná, Brazil.
MATERIAL AND METHODS
Seventy-five P. aeruginosa and 94 Acinetobacter 
spp. isolates from various clinical specimens from patients 
admitted to a public hospital in northwestern Paraná, 
Brazil, between January 2007 and July 2009 were stud-
ied. Only one isolate from each patient was selected and 
stored at -80 ºC in the Laboratory of Medical Bacteriology, 
Department of Clinical Analysis and Biomedicine, State 
University of Maringá. No personal data were retrieved 
from the patients, so privacy could be assured and legal 
transgressions concerning human research could be 
avoided (Resolution 196/96 Brazil National Health Coun-
cil, Health Ministry). The present study was approved by 
the Regulatory Commission of Academic Activities and 
Voluntary Services of the studied hospital.
Phenotypic identification and antimicrobial suscep-
tibility testing (AST) were performed using an AUTO-
SCAN-4 automated system (Siemens Microscan, Deer-
field, IL, USA), with the exception of polymyxin B for P. 
aeruginosa, which was tested by disk diffusion. The data 
were interpreted according to the criteria of the Clinical 
and Laboratory Standards Institute (CLSI; 2007-2009).
Ceftazidime-resistant P. aeruginosa and Acineto-
bacter spp. isolates were evaluated for the presence of MBL 
using the disk-approximation test, 2-mercaptopropionic 
acid (2-MPA; Acros, Bridgewater, NJ, USA), and ethyl-
enediaminetetraacetic acid (EDTA; Invitrogen, Carlsbad, 
CA, USA; Arakawa et al. 2000). IMP-1-producing Acineto-
bacter baumannii (A-3227) and P. aeruginosa ATCC 27853 
were used as positive and negative controls, respectively.
Genomic DNA of P. aeruginosa and Acinetobacter 
spp. isolates was extracted from overnight bacterial 
growth on Mueller-Hinton agar (Difco, Becton Dickinson, 
Sparks, MD, USA; Swanenburg et al., 1998). The PCRs 
were performed using primers ERIC1R (5’-ATGTA-
AGCTCCTGGGGATTCAC-3’) and ERIC2 (5’-AAGTA-
AGTGACTGGGGTGAGCG-3’) as described by Szczuka 
and Kaznowski (2004). The gels were stained with ethid-
ium bromide, and the spectral band analysis on agarose 
gels was performed using BioNumerics software (version 
4.45, Applied Maths, Sint-Martens-Latem, Belgium). The 
Dendrogram was constructed using the Dice coefficient, 
and the phylogenetic distance was determined using the 
Unweighted Pair Group Method with Arithmetic Mean 
algorithm (Sneath and Sokal, 1973). Isolates with ≥ 95% 
similarity were considered closely related.
RESULTS
The studied institution is a small-size public hospital 
with three intensive care units (ICUs): adult, pediatric, 
and neonatal. P. aeruginosa and Acinetobacter spp. were 
isolated more frequently in male patients (62.7% and 
59.6%, respectively), especially in patients older than 60 
years (54.7% and 39.4%, respectively) and in ICUs (41.4% 
and 71.3%, respectively). P. aeruginosa isolates were 
detected at a higher frequency in urine samples, whereas 
Acinetobacter spp. isolates were mainly recovered from 
tracheal aspirate.
The resistance rate in P. aeruginosa isolates was 
less than 30% for most of the b-lactam antibiotics, and 
54.6% were multiresistant (i.e., resistant to three or more 
antimicrobial classes; Magiorakos et al., 2012). All of the 
isolates were polymyxin B-susceptible. For Acinetobacter 
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spp. isolates, the b-lactam resistance rate was greater than 
90% to cephalosporins and greater than 50% to the tested 
carbapenems (Table I). Multiresistance was observed in 
91.5%. None of the P. aeruginosa (n = 39) and Acineto-
bacter spp. (n = 88) isolates with total or intermediate 
resistance to ceftazidime were positive for MBL.
The ERIC-PCR applied to P. aeruginosa and Aci-
netobacter spp. clinical isolates showed a banding pattern 
with sizes that rang, from approximately 120 pb to 1200 pb 
and 120 pb and 1900 pb, respectively.
Considering a Dice correlation coefficient ≥ 0.95, 
72 ERIC-PCR patterns were obtained in 75 P. aeruginosa 
clinical isolates. Seventy isolates (93.3%) were orphans, 
and the remaining five (6.7%) were included in two 
clusters comprising two (cluster A) and three (cluster B) 
isolates (Figure 1).
Two isolates that belonged to cluster A showed 
identical antimicrobial resistance profiles and were iso-
lated from patients in different clinical units within a time 
interval of approximately 2 months. Isolates that belonged 
to cluster B, two with 100% similarity, had equal resistance 
profiles and were isolated from patients in an adult ICU 
within a time interval of only 4 days. The third isolate that 
belonged to cluster B, despite having the same resistance 
profile, was isolated 13 days later in a patient admitted to 
the pediatric unit (Table II).
A total of 70 Acinetobacter spp. isolates (74.5%) 
showed orphan ERIC-PCR patterns, and the remaining 24 
(25.5 %) were included in 10 clusters (C-L) comprising 
two isolates each, with the exception of clusters D and H 
with three isolates each (Figure 2).
The several small clusters found in Acinetobacter 
spp. were generally detected in the same unit or units with 
displacement of patients, such as the adult ICU and medi-
cal clinic. Exceptions were observed in clusters D and J, 
which were composed of isolates from the adult and pedi-
atric ICUs. Acinetobacter clusters included isolates with 
similar resistance profiles, with some differences related 
to aminoglycosides and carbapenems. Notably, 60% of the 
small clusters were carbapenems-resistant Acinetobacter 
spp. (Table II).
TABLE I - Resistance profiles of Pseudomonas aeruginosa and 
Acinetobacter spp. isolates from inpatients in a public hospital 







Aztreonam 13 (29.3)a NT
Amikacin 30 (40.0) 53 (56.4)
Ampicillin/Sulbactam NT 21 (27.6)b
Cefepime 22 (29.3) 87 (92.5)
Ceftazidime 21 (28.0) 85 (90.4)
Ciprofloxacin 37 (49.3) 88 (93.6)
Gentamicin 33 (44.0) 70 (74.5)
Imipenem 19 (25.4) 52 (54.8)
Meropenem 19 (25.4) 53 (56.4)
Piperacillin/Tazobactam 10 (13.3) NT




NT, not tested; aTested isolates = 46; bTested isolates = 76.
FIGURE 1. Dendrogram and DNA-banding profiles that 
represent the genetic relationship among Pseudomonas 
aeruginosa isolated from clinical specimens of inpatients in a 
public hospital in northwestern Paraná, Brazil.
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TABLE II - Demographics and phenotypic and genotypic features of Pseudomonas aeruginosa and Acinetobacter spp. isolates 
with similarity ≥ 95%
Cluster Microorganism (isolate) Clinical Specimens Date of Isolation Hospital Ward Antimicrobial Resistance 
Pattern
A P. aeruginosa (786) Urine 4 Mar 2008 Pediatrics Susceptible to all tested 
antimicrobials
A P. aeruginosa (833) Tracheal aspirate 12 May 2008 Adult ICU Susceptible to all tested 
antimicrobials
B P. aeruginosa (1048) Tracheal aspirate 12 Jun 2009 Adult ICU Cip; Azt; Cef; Cfz
B P. aeruginosa (1052) Blood 8 Jun 2009 Adult ICU Cip; Azt; Cef; Cfz
B P. aeruginosa (1066) Urine 25 Jun 2009 Medical clinic Cip; Azt; Cef; Cfz
C Acinetobacter spp. (885) Urine 13 Jul 2008 Medical clinic Amp/Sul; Cip; Sut; Cef; Cfz 
C Acinetobacter spp. (893) Tracheal aspirate 14 Aug 2008 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami
D Acinetobacter spp. (1033) Tracheal aspirate 14 May 2009 Pediatric ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
D Acinetobacter spp. (1067) Tracheal aspirate 24 Jun 2009 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
D Acinetobacter spp. (1043) Tracheal aspirate 25 May 2009 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
E Acinetobacter spp. (1002) Urine 4 Mar 2009 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
E Acinetobacter spp. (1024) Blood 23 Mar 2009 Medical clinic Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
F Acinetobacter spp. (900) Tracheal aspirate 20 Aug 2008 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami
F Acinetobacter spp. (918) Tracheal aspirate 24 Sep 2008 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami
G Acinetobacter spp. (573) Urine 17 Feb 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
G Acinetobacter spp. (585) Blood 15 Mar 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Imp; Mer
H Acinetobacter spp. (559) Surgical wound 29 Jan 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
H Acinetobacter spp. (564) Tracheal aspirate 29 Jan 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
H Acinetobacter spp.(548) Tracheal aspirate 3 Jan 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
I Acinetobacter spp. (611) Tracheal aspirate 17 Apr 2007 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami; 
Imp; Mer
I Acinetobacter spp. (613) Tracheal aspirate 26 Apr 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Imp; Mer
J Acinetobacter spp. (554) Tracheal aspirate 16 Jan 2007 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami
J Acinetobacter spp. (557) Tracheal aspirate 4 Feb 2007 Pediatric ICU Cip; Sut; Cef; Cfz; Gen; Ami
K Acinetobacter spp. (566) Tracheal aspirate 22 Jan 2007 Medical clinic Cip; Sut; Cef; Cfz; Ami
K Acinetobacter spp. (568) Tracheal aspirate 15 Feb 2007 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami 
L Acinetobacter spp. (610) Tracheal aspirate 17 Apr 2007 Adult ICU Amp/Sul; Cip; Sut; Cef; Cfz; 
Gen; Ami; Imp; Mer
L Acinetobacter spp. (617) Tracheal aspirate 11 May 2007 Adult ICU Cip; Sut; Cef; Cfz; Gen; Ami 
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FIGURE 2. Dendrogram and DNA-banding profiles that 
represent the genetic relationship among Acinetobacter spp. 
isolated from clinical specimens of inpatients in a public hospital 
in northwestern Paraná, Brazil.
DISCUSSION
In the present study, the ERIC-PCR assessment and 
antimicrobial resistance profiles of P. aeruginosa and 
Acinetobacter spp. isolates from inpatients in a small-size 
teaching hospital in northwestern Paraná showed a high 
percentage of multiresistance and genetic diversity. Wor-
rying rates of ceftazidime and carbapenems resistance 
were observed in P. aeruginosa isolates. However, they 
were smaller than those observed in isolates from other 
university hospitals in Brazil, where resistance to these 
antimicrobials was near or greater than 50% (Zavascki, 
Cruz, Goldani, 2004; Rocha et al., 2008).
In recent years, MBL production has represented 
an important mechanism of resistance to most b-lactam 
antibiotics, including carbapenems, especially in P. aeru-
ginosa (Kunz, Brook, 2010). However, despite a resistance 
rate of just over 25% detected for carbapenems, none of 
the P. aeruginosa isolates tested were positive for MBL, 
demonstrating the probable participation of other resis-
tance mechanisms. The isolation rates of MBL-producing 
P. aeruginosa have widely varied among Brazilian hos-
pitals, with incidences ranging from 3.1% (Wirth et al., 
2009) to 35% (Gonçalves et al., 2009). According to Rossi 
(2011), São Paulo metallo-β-lactamase (SPM) is the most 
prevalent MBL in Brazilian isolates. For Acinetobacter 
spp. isolated in the present study, the observed resistance 
rates of > 90% for third-generation cephalosporins and 
nearly 55% for carbapenems may be responsible for the 
difficulty treating these cases, which has been reported in 
other studies (Towner, 2009; Kunz, Brook, 2010). MBL 
was not detected in isolates from this genus, which cor-
roborates other studies that found a low contribution of 
this enzyme to the increasing rates of resistance in Acineto-
bacter spp. (Mostachio et al., 2009; Kunz, Brook, 2010). 
OXA-type b-lactamases have shown an important role in 
carbapenem-resistant Acinetobacter spp. (Poirel, Naas, 
Nordmann, 2010). In Acinetobacter spp. isolates from Bra-
zilian hospitals, carbapenem resistance is mostly related 
to b-lactamase OXA-23 (Gales et al., 2012). However, a 
recent study found a high prevalence of OXA-143 in these 
bacterial genera (Mostachio et al., 2012). Therefore, the 
small clusters of carbapenem-resistant Acinetobacter spp. 
isolated in this study may have been OXA-type carbapen-
emase producers.
Although clonal spread is commonly found in hospi-
tals worldwide (Scott and Pitt, 2004; Cortes et al., 2009), 
including Brazil (Stheling, Leite, Silveira, 2010), the pres-
ent study detected high genetic diversity, especially among 
P. aeruginosa isolates. Only two (2.7%) of the 75 isolates 
showed identical ERIC-PCR patterns (100% similarity), 
and five (6.7%) had ≥ 95% similarity. However, according 
to the phenotypic features and demographic conditions, the 
cross-spread of small clusters of P. aeruginosa and Aci-
netobacter spp., including carbapenem-resistant isolates, 
among patients in the hospital, was evident. Importantly, 
however, the findings of Saalfeld et al. (2009) should be 
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considered, in which high genetic similarity was found 
among clinical and environmental Acinetobacter spp. 
isolates in an adult ICU in the same hospital from January 
to July 2008. These authors suggested that an endemic 
situation existed by observing the genotypic similarity of 
isolates using a Dice correlation coefficient > 90%.
CONCLUSION
Using ERIC-PCR, the present study found high 
genetic diversity among P. aeruginosa and Acinetobacter 
spp. isolates, suggesting that cross-contamination is not 
very frequent in the studied hospital. Because of the 
known applicability of ERIC-PCR, its good discriminatory 
power and reproducibility allowed an understanding of 
the epidemiology of these bacteria in the studied hospital 
environment.
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